menu search

OPK / OPKO Health is the Little Giant of Diversified Healthcare

OPKO Health is the Little Giant of Diversified Healthcare
Diversified healthcare company OPKO Health Inc. NASDAQ: OPK shares may be low priced, but its businesses pipeline of treatments and upside potential may deserve a higher valuation. Shares trade at 1.6X sales. Read More
Posted: Jul 19 2023, 07:14
Author Name: MarketBeat
Views: 110889

OPK News  

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

By GlobeNewsWire
October 31, 2023

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

MIAMI, Oct. 31, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months more_horizontal

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

By GlobeNewsWire
October 25, 2023

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) will present late-breaking clinical data on RAYALDEE® extended-release calci more_horizontal

OPKO Health (OPK) Gets BARDA Contract to Combat Antibody Threats

By Zacks Investment Research
October 6, 2023

OPKO Health (OPK) Gets BARDA Contract to Combat Antibody Threats

OPKO Health's (OPK) latest awarded funding is likely to enable the development of novel multispecific antibodies against viral infectious disease thre more_horizontal

OPKO Health (OPK) Ties Up for Oral Peptide Tablet Formulations

By Zacks Investment Research
September 13, 2023

OPKO Health (OPK) Ties Up for Oral Peptide Tablet Formulations

OPKO Health's (OPK) latest Research Collaboration Agreement is likely to enable it to expand its pipeline to develop orally administered tablet presen more_horizontal

Reasons to Retain OPKO Health (OPK) Stock in Your Portfolio

By Zacks Investment Research
August 28, 2023

Reasons to Retain OPKO Health (OPK) Stock in Your Portfolio

OPKO Health's (OPK) potential in RAYALDEE raises optimism about the stock. more_horizontal

OPKO Health (OPK) Q2 Earnings and Revenues Top Estimates

By Zacks Investment Research
August 7, 2023

OPKO Health (OPK) Q2 Earnings and Revenues Top Estimates

Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall second-quarter results reflect soft perform more_horizontal

OPKO Health, Inc. (OPK) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 4, 2023

OPKO Health, Inc. (OPK) Q2 2023 Earnings Call Transcript

OPKO Health, Inc. (NASDAQ:OPK ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations more_horizontal

OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates

By Zacks Investment Research
August 3, 2023

OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates

OPKO Health (OPK) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $ more_horizontal


Search within

Pages Search Results: